Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates
Follow the latest updates of the outbreak on our timeline.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
CardioQuip has received CE Mark approval for the MCH-1000 Modular Cooler-Heater Series, which is now available to the European healthcare systems dealing with the coronavirus (Covid-19) pandemic.
The MCH-1000 can be used to regulate patient temperature during different medical procedures, especially those involving the heart and lungs.
The bright TFT colour LCD of the MCH Series provides up-to-the-second information and quick temperature response.
CardioQuip said that the device can potentially be used for Extracorporeal Membrane Oxygenation (ECMO), a treatment for acute respiratory distress syndrome (ARDS) associated with Covid-19.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataECMO is said to enable increased systemic oxygen delivery and mitigates ventilator-induced lung injury.
CardioQuip CEO Doug Platt said: “Landing the CE Mark is a tremendous milestone for CardioQuip. The approval allows us to offer our technology to major hospitals all over the European Union (EU) at a time when it is greatly needed.”
The company noted that patient deaths linked to non-tuberculosis mycobacterium (NTM) growth in cooler-heaters manufactured in Europe have highlighted the need for safety and water quality in cooler-heaters.
To ensure safety, MCH-1000 features an open-tank design paired with its simplified cleaning protocol and ease of use.
Platt added: “We are excited to be in the final stages of agreements with European distribution partners to aide our commercialisation efforts and get the MCH-1000 to the EU as quickly as possible.”
CardioQuip also received ISO 134385:2016 certification of its quality management system, following the completion of an audit by the EU Notified Body, BSI.
The MCH-1000 received FDA 510(k) clearance in the US in 2011.
